Physician profile
John M Tozzi
NPI 1093794539
$3,428.26
in general payments reported to CMS, 2019-2025
16 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $160 · 2021: $394 · 2022: $327 · 2023: $15.04 · 2024: $1,951 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,348 · Food and Beverage: $522 · Education: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,348.00 |
| Food and Beverage | $521.51 |
| Education | $322.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,603.99 | 2019-2025 | Comprehensive Shoulder System, Persona |
| Depuy Synthes Sales INC. | $285.14 | 2019-2024 | Orthovisc, Monovisc |
| Medshape, INC. | $81.58 | 2022 | |
| Ferring Pharmaceuticals INC. | $76.43 | 2019-2025 | Euflexxa |
| Bioventus LLC | $66.74 | 2019-2024 | Durolane |
| Davol INC. | $46.90 | 2021 | |
| Heraeus Medical, LLC. | $43.72 | 2021-2024 | |
| Baxter Healthcare | $38.58 | 2025 | Perclot |
| Nevro Corp. | $38.21 | 2024 | Senza |
| Abbvie INC. | $33.17 | 2024 | |
| Sanofi-Aventis U.S. LLC | $29.79 | 2019-2023 | |
| Boston Scientific Corporation | $22.68 | 2025 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $18.09 | 2024 | Zilretta, Iovera, Exparel |
| Fidia Pharma USA INC. | $17.50 | 2020 | |
| Orthogenrx INC. | $14.70 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tozzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.